IMMUNOVIA AB news, videos and press releases
For more news please use our advanced search feature.
IMMUNOVIA AB - More news...
IMMUNOVIA AB - More news...
- Immunovia announces determined exercise price for warrants series TO 2 and conditionally securing 65% of the warrant programme
- Immunovia announces determined exercise price for warrants series TO 2 and conditionally securing 65% of the warrant programme
- Immunovia discovery study published in top protein research journal
- End of the Year 2024 Letter from Immunovia CEO Jeff Borcherding
- Immunovia CEO and board members announce intention to fully exercise their TO2 warrants
- Immunovia to host a webcast with the opportunity to learn more about the positive clinical validation of its next-generation pancreatic cancer test
- Immunovia announces financial calendar for financial year 2025/2026
- Immunovia announces positive outcome and strong accuracy in the clinical validation of its next-generation test for pancreatic cancer
- Immunovia to present at the Redeye Technology & Life Science Day
- Immunovia Publishes Interim Report for January-September 2024
- Immunovia Publishes Interim Report for January-September 2024
- Immunovia presents model-development study results at meeting of the Collaborative Group of the Americas--Inherited Gastrointestinal Cancers
- Invitation to Immunovia's Q3 presentation
- Invitation to Immunovia's Q3 presentation
- Immunovia presents data from model development study at meeting of the PRECEDE pancreatic cancer research consortium
- Immunovia has successfully acquired all blood samples required to clinically validate its next-generation test for pancreatic cancer
- Immunovia completes analytical validation of its next-generation pancreatic cancer test
- Change in number of shares and votes in Immunovia AB (publ)
- Change in number of shares and votes in Immunovia AB (publ)
- Immunovia presents data from model development study at 2024 AACR Advances in Pancreatic Cancer medical conference
- Immunovia Publishes Interim Report for January-June 2024
- Immunovia Publishes Interim Report for January-June 2024
- Immunovia's next-generation test to be included in large study of pancreatic cysts funded by the U.S. National Institutes of Health
- Immunovia files US patent application to protect its next-generation test
- Immunovia completes development of its pancreatic cancer detection test after substantially increasing test accuracy
- Invitation to Immunovia's Q2 presentation
- Invitation to Immunovia's Q2 presentation
- Immunovia's new lab staffed and operational after rapid implementation
- BULLETIN FROM THE ANNUAL GENERAL MEETING ON 19 JUNE 2024 IN IMMUNOVIA AB (PUBL)
- BULLETIN FROM THE ANNUAL GENERAL MEETING ON 19 JUNE 2024 IN IMMUNOVIA AB (PUBL)
